A cholesterol tweak quietly changed where mRNA goes
The mRNA revolution is hitting its stride. From vaccines that precisely target specific cells to cancer treatments that hijack the body's own immune system, researchers are pushing these molecular messengers far beyond their COVID-19 origins.
๐ฏ Smart cholesterol turns mRNA into a precision missile
Researchers cracked a major mRNA delivery problem by turning cholesterolโwhich makes up about half of all lipid nanoparticle moleculesโinto a targeting system.
Adding mannose sugar to cholesterol in lipid nanoparticles redirected mRNA away from liver cells (hepatocytes) and toward immune cells called Kupffer cells and liver sinusoidal endothelial cells
The targeting worked because these immune cells express high levels of mannose receptors (CD206), while liver cells don't
Shorter PEG chains on the nanoparticles improved targeting by allowing faster shedding in circulation, exposing more mannose for binding
Why it matters: Most mRNA therapies get trapped in liver cells due to natural protein coating, limiting their use for diseases affecting other cell types. This cholesterol modification approach could unlock mRNA treatments for immune disorders, blood vessel diseases, and other conditions requiring precise cellular targeting.
Key Findings
๐ฌ Omicron boosters work better with Pfizer than Moderna
In a 706-person clinical trial, Omicron BA.1 boosters reduced COVID-19 incidence 2.56-fold compared to original vaccine boostersโbut only for Pfizer recipients
Moderna recipients showed no difference between Omicron and original boosters (risk ratio 1.04)
The trial tracked participants for months after vaccination, measuring both antibody levels and actual COVID-19 infections
๐ Tumor-activated cancer treatment stays dormant until needed
Scientists engineered mRNA encoding a "locked" IL-12 protein that only activates when it encounters tumor-specific enzymes (MMP-2)
The system allows safe systemic delivery of a powerful immune-stimulating protein that would normally cause dangerous side effects
In mice, the approach eliminated tumors while avoiding the immune toxicity that has limited IL-12 cancer treatments
๐ซ Inhaled nanoparticles reach the liver, not just lungs
Neutral-charged mRNA nanoparticles delivered via nebulizer targeted the liver, while charged particles stayed in the lungs
In diabetes mice, inhaled delivery of insulin-like hormone mRNA (dulaglutide) controlled blood sugar effectively
In liver disease mice, inhaled enzyme mRNA helped maintain body weight and preserve liver function
๐ฉธ mRNA prevents blood clots by targeting vessel walls
Researchers developed lipid nanoparticles that specifically target blood vessel cells to deliver clot-dissolving protein mRNA
The system prevented deep vein thrombosis in mice by producing tissue plasminogen activator (TPA) directly at vessel walls
This approach avoids bleeding complications of systemic blood thinners by localizing the anti-clotting effect
๐ฆ Norovirus vaccine protects across multiple viral strains
A five-strain mRNA vaccine induced antibodies against all included norovirus types in both mice and non-human primates
The vaccine produced immune responses comparable to traditional virus-like particle vaccines but with similar durability
Noroviruses cause 18% of diarrheal disease globally with no current vaccines available
๐ง Neutrophil-hijacking nanoparticles treat stroke
Lipid nanoparticles loaded with anti-inflammatory drug exploited neutrophil migration to cross the blood-brain barrier and reach stroke sites
In mice with induced strokes, the targeted treatment reduced brain damage by 45% and cut inflammatory markers by over 50%
The approach uses neutrophils' natural tendency to rush toward damaged tissue as a delivery vehicle
Implications
These studies reveal mRNA technology's rapid evolution from simple vaccines to sophisticated therapeutic platforms. By solving targeting challenges and developing conditional activation systems, researchers are positioning mRNA treatments to address cancer, blood disorders, and neurological diseases with unprecedented precision.
Studies in this issue
Primary sources used for this newsletter.
- Mannose-coated cholesterol lipid particles for targeted mRNA delivery to liver filtering and immune cellsmain storyBioconjugate chemistry2025-09-11PMID 40934895
- COVID-19 rates after booster shots based on Omicron BA.1 versus original mRNA vaccine in the COVAIL trialkey findingVaccine2025-09-10PMID 40930044
- Inhaled lipid nanoparticles deliver mRNA to the liver to treat metabolic diseaseskey findingNano letters2025-09-08PMID 40916925
- Lipid nanoparticles use immune cells to improve anti-inflammatory and stroke treatmentkey findingActa biomaterialia2025-09-14PMID 40946735
- Using synthetic lipid nanoparticles to deliver mRNA to blood vessel lining cells to prevent vein blood clotskey findingJournal of controlled release : official journal of the Controlled Release Society2025-09-13PMID 40946051
- Using mRNA to Deliver a Tumor-Activated Immune Protein That Kills Tumors While Reducing Side Effectskey findingNano letters2025-09-10PMID 40928825
- Immune responses from mRNA vaccines producing norovirus proteins in mice and primateskey findingMolecular therapy : the journal of the American Society of Gene Therapy2025-09-14PMID 40946165
Continue reading
All mRNA Technology issuesGet the next mRNA Technology issue
Seven papers, once a week. Free.